Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-003962

Director bought 6,665 shares at an average $0.71 ($4,709)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-14 Purchase : show line 1 in the form +4,399 $0.71 $3,123 109,081 D
2019-01-15 Purchase : show line 2 in the form +2,266 $0.70 $1,586 111,347 D
Open-market purchases · 6,665 sh · avg $0.71 · $4,709
Loading xslF345X03/doc4.xml…